---
type: "examples"
title: "Group Examples"
resource: "Group"
---
# Group Examples

- [101](/group-example-101) — group-example — General Group Example, Characteristic Based
- [102](/group-example-102) — group-example-member — General Group Example, Member Based
- [example-conceptualcohortdefinition-cancer-except-subset](/group-example-example-conceptualcohortdefinition-cancer-except-subset) — group-example-conceptualcohortdefinition-cancer-except-subset — ConceptualCohortDefinition: Cancer of any kind (except basal cell skin cancer or cancer in situ) unless documented to be disease-free for five years
- [example-eligibility-criteria-ada-rec-bariatric](/group-example-example-eligibility-criteria-ada-rec-bariatric) — group-example-eligibility-criteria-ada-rec-bariatric — Inclusion Criteria: [[1]] Adults. [[2]] Diagnosed with type 2 diabetes. [[3]] Body Mass Index (BMI) ≥ 40.0 kg/m2 (BMI ≥ 37.5 kg/m2 in Asian Americans), or BMI ≥ 35.0 kg/m2 and ≤ 39.9 kg/m2 (BMI 32.5-37.4 kg/m2 in Asian Americans) who do not achieve durable weight loss and improvement in comorbidities (including hyperglycemia) with nonsurgical methods. [[4]] Screened surgical candidates.
- [example-outcomedefinition-hba1c-at-12-months](/group-example-example-outcomedefinition-hba1c-at-12-months) — group-example-outcomedefinition-hba1c-at-12-months — OutcomeDefinition: HbA1c at 12 months
- [example-patientlist](/group-example-example-patientlist) — group-example-patientlist — Patients primarily attributed to Practitioner 123
- [example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort](/group-example-example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort) — group-example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort — Stroke Thrombolysis Trialists’ Collaborators Group collection used for individual patient data meta-analysis
- [Family](/group-example-Family) — group-example-family — Example of a Family
- [group-example](/group-example-group-example) — group-example
- [group-example-conceptualcohortdefinition-cancer-except-subset](/group-example-group-example-conceptualcohortdefinition-cancer-except-subset) — group-example-conceptualcohortdefinition-cancer-except-subset
- [group-example-eligibility-criteria-ada-rec-bariatric](/group-example-group-example-eligibility-criteria-ada-rec-bariatric) — group-example-eligibility-criteria-ada-rec-bariatric
- [group-example-family](/group-example-group-example-family) — group-example-family
- [group-example-herd1](/group-example-group-example-herd1) — group-example-herd1
- [group-example-household](/group-example-group-example-household) — group-example-household
- [group-example-member](/group-example-group-example-member) — group-example-member
- [group-example-outcomedefinition-hba1c-at-12-months](/group-example-group-example-outcomedefinition-hba1c-at-12-months) — group-example-outcomedefinition-hba1c-at-12-months
- [group-example-patientlist](/group-example-group-example-patientlist) — group-example-patientlist
- [group-example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort](/group-example-group-example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort) — group-example-Stroke-Thrombolysis-Trialists-2014-2016-IPD-MA-Cohort
- [group-examples-header](/group-example-group-examples-header) — group-examples-header
- [herd1](/group-example-herd1) — group-example-herd1 — Herd of 2500 breeding sows
- [Household](/group-example-Household) — group-example-household — Example of a Household